US3828766A - Disposable medical electrode - Google Patents

Disposable medical electrode Download PDF

Info

Publication number
US3828766A
US3828766A US00280350A US28035072A US3828766A US 3828766 A US3828766 A US 3828766A US 00280350 A US00280350 A US 00280350A US 28035072 A US28035072 A US 28035072A US 3828766 A US3828766 A US 3828766A
Authority
US
United States
Prior art keywords
electrode
pad
support member
monitoring electrode
accordance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US00280350A
Inventor
D Krasnow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JET MEDICAL PROD Inc
Original Assignee
JET MEDICAL PROD Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JET MEDICAL PROD Inc filed Critical JET MEDICAL PROD Inc
Priority to US00280350A priority Critical patent/US3828766A/en
Application granted granted Critical
Publication of US3828766A publication Critical patent/US3828766A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/25Bioelectric electrodes therefor
    • A61B5/251Means for maintaining electrode contact with the body
    • A61B5/257Means for maintaining electrode contact with the body using adhesive means, e.g. adhesive pads or tapes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/25Bioelectric electrodes therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/25Bioelectric electrodes therefor
    • A61B5/263Bioelectric electrodes therefor characterised by the electrode materials
    • A61B5/265Bioelectric electrodes therefor characterised by the electrode materials containing silver or silver chloride
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/25Bioelectric electrodes therefor
    • A61B5/263Bioelectric electrodes therefor characterised by the electrode materials
    • A61B5/266Bioelectric electrodes therefor characterised by the electrode materials containing electrolytes, conductive gels or pastes

Definitions

  • ABSTRACT A disposable medical electrode comprising a support member made of a closed cell plastic material having an adhesive surface. A centrally located contact element is embedded therein so as to leave an exposed portion thereof at the adhesive side of the support member. A smaller pad member made up of an open cell plastic material is adhered to the adhesive surface of the support member at a position opposite to and in contact with the exposed portion of the contact element. In use, the pad member has a conductive gel dispersed throughout so that when the electrode is placed against the skin of a patient a good conductive path is present from the skin through the gelled pad to the contact element.
  • FIG. IA 25 DISPOSABLE MEDICAL ELECTRODE DISCLOSURE OF THE INVENTION ble between the skin area which is being monitored and the metallic contact element of the electrode so that a maximum electrical signal can be obtained for use in the monitoring equipment.
  • An improtant further characteristic of such electrodes is that they be so designed as to minimize the discomfort which a patient will suffer, especially when such electrode may be required to be used over a prolonged period of time, sometimes for several days.
  • Such electrodes provide maximum signal strength with minimal discomfort for more sensitive patients, such as adults with sensitive skin and children or infants whose skin is apt to be more tender than that of adults.
  • the comfort factor may be particularly important when used with extremely small infants, less than 30 days old, in the growing field of neo-natalogy.
  • a conventionally structured electrode presently available for use in the medical field is a type which utilizes a conductive gel between the skin area which is being contacted and the metallic contact element of the electrode to which the monitoring circuit is connected.
  • the metal contact element is normally affixed to a rigid plastic base member of the electrode, the contact element being in the form of a snap fastener assembly having a first side to which a monitoring circuit is snap connected and a second oppositely disposed side which is in contact with a pad member made of an open cell plastic material permeated with a conductive gel.
  • the pad is in turn in pressure contact with the skin, the conductive gel thereby assuring that a good conductive path is present from the skin to the metal contact element for the signal which is being monitored.
  • the gel pad is freely nested in a recessed region of the electrode which is formed by a solid ridged portion of the rigid plastic body member, the outer surface of the'ridge coming into pressure contact with the skin adjacent the outer perimeterof the gel pad when the electrode is in use.
  • the ridged body member containing the snap fastener contact element is attached to a circularly shaped open cell plastic foam material one side of which has an adhesive thereon so that the electrode can adhere to the skin.
  • the protruding ridge is thereby between the open cell adhesive foam material and the open cell-gel pad foam material to form a barrier therebetween so as to prevent the conductive gel in the gel pad from being .2 absorbed'by and dispersed throughout the open cell adhesive foam portion of the overall electrode.
  • the presence of the ridge tends to cause excessive discomfort'to the patient on whom the electrode is being used since the ridge which digs into the skin of the patient can become extremely irritating.
  • the gel pad can often fall out of its recessed nest during handling and must be replaced by hand or other means, all of which tends to cause the gel pad to become less sanitary in use than is desired.
  • the need for a ridged barrier between a conductor gel pad and an adhesive portion of the electrode is eliminated so that a relatively smooth surface is presented to the skin of the patient and any irritation and discomfort caused by the presence of a ridge is completely avoided.
  • the adhesive base member of the electrode to which a snap fastener contact element is attached is made of a plastic foam material having a closed cell configuration.
  • a gel pad made of a plastic foam material having an open cell configuration is then adhered to the underside of the closed cell foam material opposite the underside of the snap fastener contact element.
  • a thin vinyl plastic strip is adhered to the upper side of the closed cell body member to provide some rigidity thereto. Because of the closed cell nature of the adhesive base member of the electrode, substantially none of the conductive gel which is dispersed throughout the open cell gel pad can be absorbed by or dispersed within the closed cell material and the gel is adequately retained within the open cell gel pad during manufacture, shipment and use. Moreover, because no solid plastic ridged member is used, the surface of the electrode which comes into contact with the skin of the patient is essentially soft and relatively smooth with no protruding ridges so that it can be readily placed on the patients skin for good adherence without discomfort even with prolonged use.
  • the lower surface of the contact element which is in contact with the gel pad may be coated with silver so that, in reacting with the gel substance a silver/silver chloride conductive coating is formed which enhances the signal carrying properties of the electrode.
  • FIG. 1 shows a view in cross-section of a monitoring electrode of the prior art
  • FIG. 1A shows a plan view of the electrode of FIG.
  • FIG. 2 shows a view in cross-section of a preferred embodiment of the electrode in accordance with the invention
  • FIG. 2A shows a plan view of the electrode of FIG.
  • FIG. 3 shows a view in cross-section of a portion of the electrode of FIG. 2;
  • FIG. 4 shows a view in cross-section of a preferred embodiment for packaging one or more of the electrodes of FIG. 2.
  • FIG. 1 depicts a conventional monitoring electrode of the prior art which has found relatively widespread use in the medical field at the present time.
  • the electrode comprises a solid plastic ridged body member having an upper portion 11A and a lower portion 11B, each of a circular configuration, which portions each include flat body portions 12A and 128 respectively, and ridged portions 13A and 13B, respectively, forming the outer peripheries thereof.
  • a contact element 14 is positioned within apertures at the centers of solid portions 11A and 118, the contact element being in the form of a conventional male snap fastener having a first upper portion 14A with a protruding snap at the center thereof and a lower portion 148 which nests within the upper portion so that the overall element can be attached to and retained in the solid ridged member.
  • the snap fastener 14 provides a snap contact to a corresponding female snap fastener (not shown) which is in turn connected to an appropriate lead for connection to suitable monitoring equipment (also not shown).
  • the upper and lower solid portions 11A and 118 may be made of any appropriately chosen plastic material and are arranged to enclose an adhesive pad member 16 also of substantially circular configuration, as shown.
  • foam pad 16 has a layer 17 of double faced adhesive material placed thereon and extending from ridge 138 to the periphery thereof so as to provide an adhesion surface which permits the electrode to be placed in an adhering manner on the skin of a patient.
  • a circular pad 19 of foam plastic material is nested within the recess 18 formed by ridge 13B, pad 19 being substantially permeated with a conductive gel substance forming a gel pad for providing a good conductive path from the skin which contacts the outer exposed surface thereof and the lower portion 148 of contact element 14, which is in contact with the inner surface of gel pad 19.
  • Gel pad 19 is retained within the recess 18 by the surface tension action of the gel on the underside of solid plastic portion 12B,
  • both of the plastic pad materials forming the adhesive pad 16 and the gel pad 19 are made of an open cellular plastic foam material which is readily absorbent to liquids and gels which can thereby penetrate into and become dispersed throughout such materials.
  • the ridge 13B and body portion 128 form a barrier so that none of the gel in gel pad 19 comes into contact with the adhesive pad 16.
  • the conductivity of the path through pad 19 would be greatly reduced and the effectiveness of the electrode would become diminished.
  • ridge 13B tends to dig into the skin and become so irritating that a high degree of discomfort may result, particularly with patients having relatively tender skin.
  • the presence of ridge 13B tends to cause the adhesive surfaces in the regions adjacent the ridges to be raised out of contact with the skin so that the area of adhesive contact with the skin is reduced.
  • the diameter of the overall electrode must be made relatively large and the electrode becomes less useful for some applications.
  • FIGS. 2 and 2A A preferred embodiment of the monitoring electrode of the invention is depicted in FIGS. 2 and 2A and shows the contrast between the structure thereof and that of the prior art electrode shown in FIGS. 1 and 1A.
  • the electrode 20 of the invention comprises an adhesive foam pad portion 21 which forms the main body of the electrode and has on one surface thereof a layer 22 of double-faced adhesive which effectively covers the entire surface.
  • adhesive foam pad 21 has a substantially circular configuration and at the central region of the surface 24 opposite to the adhesive surface thereof a paper thin circular piece 23 of vinyl plastic material is positioned.
  • Vinyl piece 23 imparts a slightly greater degree of rigidity for the surface 24 of the electrode than to the adhesive surface thereof and, further, can be used as an appropriate label for identifying the electrode and the manufacturer thereof.
  • a snap fastener contact element 25 is machine fastened at the center of adhesive foam pad 21 as shown. After the fastening process the presence of fastener 25 forms slight depressions at both the upper and the lower surfaces of foam pad 21, as shown. The peripheral region of a gel pad 26 is caused to adhere to the adhesive surface of pad 21 so that the pad 26 is placed at a position opposite the lower contact surface 25A of contact element 25 as shown in enlarged detail in FIG. 3.
  • Adhesive foam pad 21 is made of a closed cell plastic material, such as a closed cell polyethylene or polyurethane plastic material, while gel pad 26 is made of an open cell material, such as polyurethane foam material.
  • a closed cell material for pad 21 effectively prevents any penetration through the pad 21 of any conductive gel which is present in gel pad 26 within which it is in contact.
  • One such closed cell plastic successfully used in the electrode of the invention is a polyethylene plastic sold under the name Volara" by the Voltech Company of Lawrence, Massachusetts.
  • One such open cell gel pad material which has been successfully used to provide the necessary gel dispersion action is a polyurethane foam material sold by Rogers Foam Company, Somerville, Massachusetts.
  • the double sided adhesive layer 22 is selected so as to avoid causing any irritation to the skin, to which it adheres.
  • Adhesive No. 1524 One such adhesive which has been successfully used and which has been approved for such use by the Federal Drug Administration of the United States Government is identified as Adhesive No. 1524, made by 3M Company, Minneapolis, Minnesota.
  • the cellular density of open cell material 26 is such as to be sufficiently dense to hold a conductive gel within the material and at the same time sufficiently porous to allow the gel to penetrate throughout the material so that a good electrical contact is made between the skin of the patient and the lower surface 25A of contact element 25.
  • Conductive gels for this purpose are readily available to those in the art and any convenient gel such as that identified as Spectra 360 as sold by Parker Laboratories, lrvington, New Jersey, may be used in the electrode of the invention.
  • the bottom surface 25A thereof is coated with silver.
  • the conductive gel comes into contact with the silver coated surface thereof it forms a combination silver/silver chloride coating which enhances the conductive properties therebetween.
  • contact with electrode conductive gels often causes the formation of an acid coating which may be injurious to the skin against which the electrode is pressed.
  • the silver/silver chloride coating not only has been found to increase the conductivity of the overall electrode, it has also been found to be essentially harmless to the skin of the patient. It can also be seen that when the electrode is applied to the skin of a patient, gel pad.26 is effectively compressed and the lower surface of the electrode forms an effectively soft and smooth contact with the skin over its entire area and little or no discomfort is felt by the patient.
  • the thickness of the adhesive foam pad 21 preferably lies within a range of from 1/ 32nd of an inch to about 3/ l6ths of an inch, with a thickness of about 1/ 1 6th of an inch being successfully used in a preferred embodiment of the electrode.
  • the thickness is primarily selected so as toretain sufficient flexibility for the overall electrode to permit it to be used in various skin areas, even those having a relatively deep curvature.
  • the adhesive foam pad portion is at least l/32nd of aninch thick, it becomes much easier to remove the electrode both from the card on which it is shipped, as described below, and
  • the vinyl label 23 has been found preferably to have a diameter lying 0etween about 0.75 inches to up to the diameter of the foam pad 16.
  • the latter preferably has a diameter of from about 1 inch to 2 /4 inches and in a preferred embodiment a diameter of 1% inches hasbeen found to be satisfactory for use not only on adult patients but also on child and infant patients.
  • the diameter of gel pad 26 is preferably between about ll/l6 inch and l3/l6 inch with a diameter of about /1 inch being successfully used in a preferred embodiment.
  • the gel pad must be sufficiently large to cover the bottom contact element surface and yet have enough surface area in contact with the adhesive layer 22 to permit the gel pad to be adequately.
  • the electrode in shipping the overall electrode the electrode can be shipped either in a dry form, that is, a form wherein the gel is not applied to the open cell pad 26 until just prior to use, or in a wet" form, that is, where the gel is applied when the electrode is packaged so that it arrives for use in a pre-gelled" state.
  • a dry form that is, a form wherein the gel is not applied to the open cell pad 26 until just prior to use
  • a wet that is, where the gel is applied when the electrode is packaged so that it arrives for use in a pre-gelled” state.
  • a clear plastic cover-member 32 having relatively rigid raised portions 33 positioned above each gel pad 26, as shown.
  • Cover member 32 may be appropriately fastened with adhesive material, such as a suitable glue, at appropriate pointson the lower surface of the card.
  • Each card may be inserted into an hermetically sealed bag 35 which also has a light opaque inner surface.
  • the hermetically sealedbag prevents theescapeof any mois ture from-the gel and keeps the gel pad 26 in an appropriately wet conductive state.
  • the use of a light opaque bag 'prevents the penetration into the interior of the bagof ultraviolet rays which may cause a deterioration of the adhesive, layer 22. Accordingly, when-the electrode-is ready for use it will adhere firmly to the skin-without any problems.
  • the semi-rigid cover 32 prevents the gel pad from being inadvertently squeezed during shipment which action would cause an irretrievable loss of the gel material.
  • the electrodes of the, inventioma sheetof closedcell plastic foam material is coveredon one surface thereof with a double sided layer of adhesive material.
  • a plurality of vinyl labels are then adhered at various regions to the opposite side thereof andthe snap fasteners 25 are machine installed at the centerof 'each vinyl label.
  • a pluralityof open cell foam plastic pads are thenadhered to the adhesive layer of the closed cell material at positions opposite'each snap fastener. The open cell pads can be so applied ina dry. state and the electrodes then appropriately punched out from the closed cell plastic sheet. If ltilS desired to ship the electrodes in a wet state, a conductive gel is applied to each of the gel pads before packag-, mg.
  • one or more of the punchedelectrodes are mounted on a card having one ormore circular apertures each having a diameter the sameas that of the open cell gel pads and the relatively rigid plastic cover is then glued to thsurface of the card through which the open cell gel pad protrudes.
  • Thecards are then placed into hermetically scalable and light opaque. bags and appropriately sealed for storage and/or shipment.
  • a monitoring electrode comprising a substantially flat support member formed of plastic foam material having a closed cellular configuration throughout, one surface of which is adhesive;
  • a contact element embedded in said support member, a first contact portion thereof being exposed atsaid one surface and a second contact portion thereof protruding from the opposite surface of said support member;
  • a pad member formed of plastic foam material having an open cellular configuration adhered to said adhesive surface of said support member at a position such that the inner surface of said pad member is in contact with and substantially covers said exposed portion of said contact element, the outer surface thereof being capable of contacting a surface to be monitored.
  • said support member is substantially circular in configuration and has a diameter of about l% inches.

Abstract

A disposable medical electrode comprising a support member made of a closed cell plastic material having an adhesive surface. A centrally located contact element is embedded therein so as to leave an exposed portion thereof at the adhesive side of the support member. A smaller pad member made up of an open cell plastic material is adhered to the adhesive surface of the support member at a position opposite to and in contact with the exposed portion of the contact element. In use, the pad member has a conductive gel dispersed throughout so that when the electrode is placed against the skin of a patient a good conductive path is present from the skin through the gelled pad to the contact element.

Description

ilnited States Patent 191 Krasnow [451 Aug. 13, 1974 [73] Assignee: Jet Medical Products Inc., Braintree,
Mass.
[22] Filed: Aug. 14, 1972 [21] Appl. No.: 280,350
[52] US. Cl. 128/21. E, 128/417, l28/D1G. 4 [51] Int. Cl A61b 5/04 [58] Field of Search 128/206 E, 2.1 E, DIG. 4,
[56] References Cited UNITED STATES PATENTS Karnofsky 128/417 X 3,701,346 10/1972 Patrick et a1 128/206 E Primary Examiner-Richard A. Gaudet Assistant Examiner-Lee S. Cohen Attorney, Agent, or Firm-Dike, Bronstein, Roberts & Cushman [5 7] ABSTRACT A disposable medical electrode comprising a support member made of a closed cell plastic material having an adhesive surface. A centrally located contact element is embedded therein so as to leave an exposed portion thereof at the adhesive side of the support member. A smaller pad member made up of an open cell plastic material is adhered to the adhesive surface of the support member at a position opposite to and in contact with the exposed portion of the contact element. In use, the pad member has a conductive gel dispersed throughout so that when the electrode is placed against the skin of a patient a good conductive path is present from the skin through the gelled pad to the contact element.
11 Claims, 6 Drawing Figures PATENTEDMIBI 3 14 3.828.766
llgifllllll&
FIG!
FIG. IA 25 DISPOSABLE MEDICAL ELECTRODE DISCLOSURE OF THE INVENTION ble between the skin area which is being monitored and the metallic contact element of the electrode so that a maximum electrical signal can be obtained for use in the monitoring equipment. An improtant further characteristic of such electrodes is that they be so designed as to minimize the discomfort which a patient will suffer, especially when such electrode may be required to be used over a prolonged period of time, sometimes for several days.
It is particularly desirable that such electrodes provide maximum signal strength with minimal discomfort for more sensitive patients, such as adults with sensitive skin and children or infants whose skin is apt to be more tender than that of adults. The comfort factor may be particularly important when used with extremely small infants, less than 30 days old, in the growing field of neo-natalogy.
DESCRIPTION OF THE PRIOR ART A conventionally structured electrode presently available for use in the medical field is a type which utilizes a conductive gel between the skin area which is being contacted and the metallic contact element of the electrode to which the monitoring circuit is connected. In such presently used electrodes the metal contact element is normally affixed to a rigid plastic base member of the electrode, the contact element being in the form of a snap fastener assembly having a first side to which a monitoring circuit is snap connected and a second oppositely disposed side which is in contact with a pad member made of an open cell plastic material permeated with a conductive gel. The pad is in turn in pressure contact with the skin, the conductive gel thereby assuring that a good conductive path is present from the skin to the metal contact element for the signal which is being monitored.
In such prior art electrodes the gel pad is freely nested in a recessed region of the electrode which is formed by a solid ridged portion of the rigid plastic body member, the outer surface of the'ridge coming into pressure contact with the skin adjacent the outer perimeterof the gel pad when the electrode is in use. The ridged body member containing the snap fastener contact element is attached to a circularly shaped open cell plastic foam material one side of which has an adhesive thereon so that the electrode can adhere to the skin. The protruding ridge is thereby between the open cell adhesive foam material and the open cell-gel pad foam material to form a barrier therebetween so as to prevent the conductive gel in the gel pad from being .2 absorbed'by and dispersed throughout the open cell adhesive foam portion of the overall electrode. Unfortunately, however, the presence of the ridge tends to cause excessive discomfort'to the patient on whom the electrode is being used since the ridge which digs into the skin of the patient can become extremely irritating.
Moreover, since the gel pad itself is held within the recessed portion of the electrode only by means of the surface tension created between the gel material and the surface of the solid ridged member of the electrode,
the gel pad can often fall out of its recessed nest during handling and must be replaced by hand or other means, all of which tends to cause the gel pad to become less sanitary in use than is desired.
SUMMARY OF THE INVENTION In the monitoring electrode of the invention the need for a ridged barrier between a conductor gel pad and an adhesive portion of the electrode is eliminated so that a relatively smooth surface is presented to the skin of the patient and any irritation and discomfort caused by the presence of a ridge is completely avoided. In the structure of the invention, the adhesive base member of the electrode to which a snap fastener contact element is attached is made of a plastic foam material having a closed cell configuration. A gel pad made of a plastic foam material having an open cell configuration is then adhered to the underside of the closed cell foam material opposite the underside of the snap fastener contact element.
In one preferred embodiment of the invention a thin vinyl plastic strip is adhered to the upper side of the closed cell body member to provide some rigidity thereto. Because of the closed cell nature of the adhesive base member of the electrode, substantially none of the conductive gel which is dispersed throughout the open cell gel pad can be absorbed by or dispersed within the closed cell material and the gel is adequately retained within the open cell gel pad during manufacture, shipment and use. Moreover, because no solid plastic ridged member is used, the surface of the electrode which comes into contact with the skin of the patient is essentially soft and relatively smooth with no protruding ridges so that it can be readily placed on the patients skin for good adherence without discomfort even with prolonged use.
In the preferred embodiment of the invention the lower surface of the contact element which is in contact with the gel pad may be coated with silver so that, in reacting with the gel substance a silver/silver chloride conductive coating is formed which enhances the signal carrying properties of the electrode.
The elimination of the need for a ridged barrier also permits the formation of a relatively smaller electrode than that of presently available electrodes and permits their use with regions of the body where the larger electrodes have not-been readily useable. A smaller size also makes the electrode more convenient for use with child and infant patients.
The invention is described in more detail with reference to the attached drawings wherein FIG. 1 shows a view in cross-section of a monitoring electrode of the prior art;
FIG. 1A shows a plan view of the electrode of FIG.
FIG. 2 shows a view in cross-section of a preferred embodiment of the electrode in accordance with the invention;
FIG. 2A shows a plan view of the electrode of FIG.
FIG. 3 shows a view in cross-section of a portion of the electrode of FIG. 2; and
FIG. 4 shows a view in cross-section of a preferred embodiment for packaging one or more of the electrodes of FIG. 2.
FIG. 1 depicts a conventional monitoring electrode of the prior art which has found relatively widespread use in the medical field at the present time. As can be seen therein the electrode comprises a solid plastic ridged body member having an upper portion 11A and a lower portion 11B, each of a circular configuration, which portions each include flat body portions 12A and 128 respectively, and ridged portions 13A and 13B, respectively, forming the outer peripheries thereof. A contact element 14 is positioned within apertures at the centers of solid portions 11A and 118, the contact element being in the form of a conventional male snap fastener having a first upper portion 14A with a protruding snap at the center thereof and a lower portion 148 which nests within the upper portion so that the overall element can be attached to and retained in the solid ridged member. The snap fastener 14 provides a snap contact to a corresponding female snap fastener (not shown) which is in turn connected to an appropriate lead for connection to suitable monitoring equipment (also not shown). The upper and lower solid portions 11A and 118 may be made of any appropriately chosen plastic material and are arranged to enclose an adhesive pad member 16 also of substantially circular configuration, as shown. One side of foam pad 16 has a layer 17 of double faced adhesive material placed thereon and extending from ridge 138 to the periphery thereof so as to provide an adhesion surface which permits the electrode to be placed in an adhering manner on the skin of a patient. A circular pad 19 of foam plastic material is nested within the recess 18 formed by ridge 13B, pad 19 being substantially permeated with a conductive gel substance forming a gel pad for providing a good conductive path from the skin which contacts the outer exposed surface thereof and the lower portion 148 of contact element 14, which is in contact with the inner surface of gel pad 19. Gel pad 19 is retained within the recess 18 by the surface tension action of the gel on the underside of solid plastic portion 12B,
In the prior art structure shown both of the plastic pad materials forming the adhesive pad 16 and the gel pad 19 are made of an open cellular plastic foam material which is readily absorbent to liquids and gels which can thereby penetrate into and become dispersed throughout such materials. In order to permit dispersion of conductive gel throughout gel pad 19 without permitting a similar dispersionin the adhesive pad 16, the ridge 13B and body portion 128 form a barrier so that none of the gel in gel pad 19 comes into contact with the adhesive pad 16. Were the conductive gel to become dispersed throughout adhesive pad 16 as well as gel pad 19, the conductivity of the path through pad 19 would be greatly reduced and the effectiveness of the electrode would become diminished. Further, when the prior art electrode 10 is placed on the skin of a patient for any prolonged period of time, ridge 13B tends to dig into the skin and become so irritating that a high degree of discomfort may result, particularly with patients having relatively tender skin.
Moreover, when the electrode has been placed on the skin the presence of ridge 13B tends to cause the adhesive surfaces in the regions adjacent the ridges to be raised out of contact with the skin so that the area of adhesive contact with the skin is reduced. In order to assure that the surface area of adhesive contact is sufficient, the diameter of the overall electrode must be made relatively large and the electrode becomes less useful for some applications.
A preferred embodiment of the monitoring electrode of the invention is depicted in FIGS. 2 and 2A and shows the contrast between the structure thereof and that of the prior art electrode shown in FIGS. 1 and 1A.
As can be seen in FIGS. 2 and 2A, the electrode 20 of the invention comprises an adhesive foam pad portion 21 which forms the main body of the electrode and has on one surface thereof a layer 22 of double-faced adhesive which effectively covers the entire surface. In a preferred embodiment adhesive foam pad 21 has a substantially circular configuration and at the central region of the surface 24 opposite to the adhesive surface thereof a paper thin circular piece 23 of vinyl plastic material is positioned. Vinyl piece 23 imparts a slightly greater degree of rigidity for the surface 24 of the electrode than to the adhesive surface thereof and, further, can be used as an appropriate label for identifying the electrode and the manufacturer thereof.
A snap fastener contact element 25 is machine fastened at the center of adhesive foam pad 21 as shown. After the fastening process the presence of fastener 25 forms slight depressions at both the upper and the lower surfaces of foam pad 21, as shown. The peripheral region of a gel pad 26 is caused to adhere to the adhesive surface of pad 21 so that the pad 26 is placed at a position opposite the lower contact surface 25A of contact element 25 as shown in enlarged detail in FIG. 3.
Adhesive foam pad 21 is made of a closed cell plastic material, such as a closed cell polyethylene or polyurethane plastic material, while gel pad 26 is made of an open cell material, such as polyurethane foam material. The use of a closed cell material for pad 21 effectively prevents any penetration through the pad 21 of any conductive gel which is present in gel pad 26 within which it is in contact. One such closed cell plastic successfully used in the electrode of the invention is a polyethylene plastic sold under the name Volara" by the Voltech Company of Lawrence, Massachusetts. One such open cell gel pad material which has been successfully used to provide the necessary gel dispersion action is a polyurethane foam material sold by Rogers Foam Company, Somerville, Massachusetts.
Further, the double sided adhesive layer 22 is selected so as to avoid causing any irritation to the skin, to which it adheres. One such adhesive which has been successfully used and which has been approved for such use by the Federal Drug Administration of the United States Government is identified as Adhesive No. 1524, made by 3M Company, Minneapolis, Minnesota.
The cellular density of open cell material 26 is such as to be sufficiently dense to hold a conductive gel within the material and at the same time sufficiently porous to allow the gel to penetrate throughout the material so that a good electrical contact is made between the skin of the patient and the lower surface 25A of contact element 25. Conductive gels for this purpose are readily available to those in the art and any convenient gel such as that identified as Spectra 360 as sold by Parker Laboratories, lrvington, New Jersey, may be used in the electrode of the invention.
in order to enhance the conductive path from the skin to the contact element 25, the bottom surface 25A thereof is coated with silver. When the conductive gel comes into contact with the silver coated surface thereof it forms a combination silver/silver chloride coating which enhances the conductive properties therebetween. In using conventional snap fasteners which have chrome plated surfaces, for example, contact with electrode conductive gels often causes the formation of an acid coating which may be injurious to the skin against which the electrode is pressed. The silver/silver chloride coating not only has been found to increase the conductivity of the overall electrode, it has also been found to be essentially harmless to the skin of the patient. It can also be seen that when the electrode is applied to the skin of a patient, gel pad.26 is effectively compressed and the lower surface of the electrode forms an effectively soft and smooth contact with the skin over its entire area and little or no discomfort is felt by the patient.
With reference to the dimensions of the various.ele ments of the electrode of the invention, it has been found that the thickness of the adhesive foam pad 21 preferably lies within a range of from 1/ 32nd of an inch to about 3/ l6ths of an inch, with a thickness of about 1/ 1 6th of an inch being successfully used in a preferred embodiment of the electrode. The thickness is primarily selected so as toretain sufficient flexibility for the overall electrode to permit it to be used in various skin areas, even those having a relatively deep curvature. Moreover, it has been found that if the adhesive foam pad portion is at least l/32nd of aninch thick, it becomes much easier to remove the electrode both from the card on which it is shipped, as described below, and
from the skin after use.
The vinyl label 23 has been found preferably to have a diameter lying 0etween about 0.75 inches to up to the diameter of the foam pad 16. The latter preferably has a diameter of from about 1 inch to 2 /4 inches and in a preferred embodiment a diameter of 1% inches hasbeen found to be satisfactory for use not only on adult patients but also on child and infant patients.
The diameter of gel pad 26 is preferably between about ll/l6 inch and l3/l6 inch with a diameter of about /1 inch being successfully used in a preferred embodiment. Thus, the gel pad must be sufficiently large to cover the bottom contact element surface and yet have enough surface area in contact with the adhesive layer 22 to permit the gel pad to be adequately. attached to the foam pad 21 about its entire periphery. Since the gel pad 26 is retained on foam'pad 21'by the adhesive layer 22 it doesnot depend for its retention upon the surface tension ofthe gel itself. Accordingly, in shipping the overall electrode the electrode can be shipped either in a dry form, that is, a form wherein the gel is not applied to the open cell pad 26 until just prior to use, or in a wet" form, that is, where the gel is applied when the electrode is packaged so that it arrives for use in a pre-gelled" state. Such a construction is in contrast with that of theprior art where the V gel must'beshipped in a wet state so as to be retained gel pads are further protected by applying a clear plastic cover-member 32 having relatively rigid raised portions 33 positioned above each gel pad 26, as shown. Cover member 32 may be appropriately fastened with adhesive material, such as a suitable glue, at appropriate pointson the lower surface of the card.
Each card may be inserted into an hermetically sealed bag 35 which also has a light opaque inner surface. If the, electrode is of a pre-gelled form, the hermetically sealedbag prevents theescapeof any mois ture from-the gel and keeps the gel pad 26 in an appropriately wet conductive state. The use of a light opaque bag'prevents the penetration into the interior of the bagof ultraviolet rays which may cause a deterioration of the adhesive, layer 22. Accordingly, when-the electrode-is ready for use it will adhere firmly to the skin-without any problems. The semi-rigid cover 32 prevents the gel pad from being inadvertently squeezed during shipment which action would cause an irretrievable loss of the gel material.
In manufacturing the electrodes of the, inventioma sheetof closedcell plastic foam material is coveredon one surface thereof with a double sided layer of adhesive material. A plurality of vinyl labelsare then adhered at various regions to the opposite side thereof andthe snap fasteners 25 are machine installed at the centerof 'each vinyl label. A pluralityof open cell foam plastic pads are thenadhered to the adhesive layer of the closed cell material at positions opposite'each snap fastener. The open cell pads can be so applied ina dry. state and the electrodes then appropriately punched out from the closed cell plastic sheet. If ltilS desired to ship the electrodes in a wet state, a conductive gel is applied to each of the gel pads before packag-, mg.
Whether in a wet or in a dry state, one or more of the punchedelectrodes are mounted on a card having one ormore circular apertures each having a diameter the sameas that of the open cell gel pads and the relatively rigid plastic cover is then glued to thsurface of the card through which the open cell gel pad protrudes. Thecards are then placed into hermetically scalable and light opaque. bags and appropriately sealed for storage and/or shipment.
What is claimed is: l. A monitoring electrode comprising a substantially flat support member formed of plastic foam material having a closed cellular configuration throughout, one surface of which is adhesive;
a contact element embedded in said support member, a first contact portion thereof being exposed atsaid one surface and a second contact portion thereof protruding from the opposite surface of said support member;
a pad member formed of plastic foam material having an open cellular configuration adhered to said adhesive surface of said support member at a position such that the inner surface of said pad member is in contact with and substantially covers said exposed portion of said contact element, the outer surface thereof being capable of contacting a surface to be monitored.
2. A monitoring electrode in accordance with claim 1 and further including a conductive gel being dispersed throughout said pad member when said monitoring electrode is in use to provide a conductive path from said outer surface of said pad member to said second contact portion.
3. A monitoring electrode in accordance with claim 2 and further including a plastic strip adhered to a portion of said opposite surface of said support member to impart greater rigidity to said opposite surface than to said one surface thereof.
4. A monitoring electrode in accordance with claim 2 wherein the thickness of said support member is in a range from about 1/32 inch to about 3/16 inches.
5. A monitoring electrode in accordance with claim 4 wherein the thickness of said support member is about l/l6 inch.
8 wherein said support member is substantially circular in configuration and has a diameter of about l% inches.
10. A monitoring electrode in accordance with claim 8 wherein said pad member is substantially circular in configuration and has a diameter in a range from about 1 H16 inches to about 13/16 inches. 11. A monitoring electrode in accordance with claim 10 wherein said pad member is substantially circular in configuration and has a diameter of about inches.

Claims (11)

1. A monitoring electrode comprising a substantially flat support member formed of plastic foam material having a closed cellular configuration throughout, one surface of which is adhesive; a contact element embedded in said support member, a first contact portion thereof being exposed at said one surface and a second contact portion thereof protruding from the opposite surface of said support member; a pad member formed of plastic foam material having an open cellular configuration adhered to said adhesive surface of said support member at a position such that the inner surface of said pad member is in contact with and substantially covers said exposed portion of said contact element, the outer surface thereof being capable of contacting a surface to be monitored.
2. A monitoring electrode in accordance with claim 1 and further including a conductive gel being dispersed throughout said pad member when said monitoring electrode is in use to provide a conductive path from said outer surface of said pad member to said second contact portion.
3. A monitoring electrode in accordance with claim 2 and further including a plastic strip adhered to a portion of said opposite surface of said support member to impart greater rigidity to said opposite surface than to said one surface thereof.
4. A monitoring electrode in accordance with claim 2 wherein the thickness of said support member is in a range from about 1/32 inch to about 3/16 inches.
5. A monitoring electrode in accordance with claim 4 wherein the thickness of said support member is about 1/16 inch.
6. A monitoring electrode in accordance with claim 2 wherein the thickness of said pad member is in a range from about 1/32 inch to about 3/32 inches.
7. A monitoring electrode in accordance with claim 6 wherein the thickness of said pad member is about 1/16 inch.
8. A monitoring electrode in accordance with claim 2 wherein said support member is substantially circular in configuration and has a diameter in a range from about 1 inch to about 2.25 inches.
9. A monitoring electrode in accordance with claim 8 wherein said support member is substantially circular in configuration and has a diameter of about 1 3/8 inches.
10. A monitoring electrode in accordance with claim 8 wherein said pad member is substantially circular in configuration and has a diameter in a range from about 11/16 inches to about 13/16 inches.
11. A monitoring electrode in accordance with claim 10 whereiN said pad member is substantially circular in configuration and has a diameter of about 3/4 inches.
US00280350A 1972-08-14 1972-08-14 Disposable medical electrode Expired - Lifetime US3828766A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US00280350A US3828766A (en) 1972-08-14 1972-08-14 Disposable medical electrode

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00280350A US3828766A (en) 1972-08-14 1972-08-14 Disposable medical electrode

Publications (1)

Publication Number Publication Date
US3828766A true US3828766A (en) 1974-08-13

Family

ID=23072707

Family Applications (1)

Application Number Title Priority Date Filing Date
US00280350A Expired - Lifetime US3828766A (en) 1972-08-14 1972-08-14 Disposable medical electrode

Country Status (1)

Country Link
US (1) US3828766A (en)

Cited By (152)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923042A (en) * 1973-10-15 1975-12-02 Medicor Muevek Electrical detector/transducer/applicable on the skin surface for biometrical observations
US3961623A (en) * 1975-01-17 1976-06-08 Medical Research Laboratories, Inc. Method of using a disposable electrode pad
US3964469A (en) * 1975-04-21 1976-06-22 Eastprint, Inc. Disposable electrode
US3972329A (en) * 1974-11-25 1976-08-03 Kaufman John George Body electrode for electro-medical use
US3973557A (en) * 1975-04-21 1976-08-10 Allison Kenneth C Electrode
US3976055A (en) * 1973-12-17 1976-08-24 Ndm Corporation Electrode and conductor therefor
US3977392A (en) * 1975-04-21 1976-08-31 Eastprint, Inc. Medical electrode
US3989035A (en) * 1975-08-04 1976-11-02 Stemmen Laboratory, Inc. Disposable medical electrode
US3993049A (en) * 1974-12-26 1976-11-23 Kater John A R Electrodes and materials therefor
US4029086A (en) * 1975-08-11 1977-06-14 Consolidated Medical Equipment, Inc. Electrode arrangement
US4034854A (en) * 1976-07-16 1977-07-12 M I Systems, Inc. Electrode package
US4040412A (en) * 1974-08-09 1977-08-09 Sato Takuya R Bioelectrodes
US4050453A (en) * 1976-02-03 1977-09-27 Concept, Inc. Radiotransparent electrode
US4067322A (en) * 1974-07-19 1978-01-10 Johnson Joseph H Disposable, pre-gel body electrodes
US4077398A (en) * 1974-10-07 1978-03-07 Baxter Travenol Laboratories, Inc. Diagnostic electrode assembly
US4077397A (en) * 1974-10-07 1978-03-07 Baxter Travenol Laboratories, Inc. Diagnostic electrode assembly
US4092985A (en) * 1974-11-25 1978-06-06 John George Kaufman Body electrode for electro-medical use
WO1979000042A1 (en) * 1977-07-13 1979-02-08 A Mercuri Biomedical electrode assembly
DE2735050A1 (en) * 1977-08-03 1979-02-08 Siemens Ag Electrode accepting and sending physiological signals - contains polyether foam inserts having closed pore surface on application side
EP0000759A1 (en) * 1977-08-03 1979-02-21 Siemens Aktiengesellschaft Electrode
FR2416001A1 (en) * 1978-02-01 1979-08-31 Bard Inc C R BIPOLAR TRANSCUTANEOUS ELECTRODE
US4166456A (en) * 1977-01-17 1979-09-04 Vaughn Corporation Carrier release sheet
US4196737A (en) * 1978-04-21 1980-04-08 C. R. Bard, Inc. Transcutaneous electrode construction
US4319579A (en) * 1979-06-21 1982-03-16 Ndm Corporation Reusable medical electrode having disposable electrolyte carrier
US4327737A (en) * 1980-05-15 1982-05-04 Roman Szpur Medical electrode assembly
US4353373A (en) * 1980-04-17 1982-10-12 Ferris Manufacturing Corp. EKG Electrode and package
US4393584A (en) * 1979-12-06 1983-07-19 C. R. Bard, Inc. Method of manufacture of electrode construction
US4441500A (en) * 1980-04-17 1984-04-10 Ferris Manufacturing Corp. EKG Electrode
US4522211A (en) * 1979-12-06 1985-06-11 C. R. Bard, Inc. Medical electrode construction
US4524775A (en) * 1982-02-15 1985-06-25 Jan Rasmussen Medical electrode and a method of manufacturing same
US4543958A (en) * 1979-04-30 1985-10-01 Ndm Corporation Medical electrode assembly
US4584962A (en) * 1979-04-30 1986-04-29 Ndm Corporation Medical electrodes and dispensing conditioner therefor
US4590089A (en) * 1979-04-30 1986-05-20 Ndm Corporation Medical electrodes and dispensing conditioner therefor
US4669479A (en) * 1985-08-21 1987-06-02 Spring Creek Institute, Inc. Dry electrode system for detection of biopotentials
US4674511A (en) * 1979-04-30 1987-06-23 American Hospital Supply Corporation Medical electrode
US4685467A (en) * 1985-07-10 1987-08-11 American Hospital Supply Corporation X-ray transparent medical electrodes and lead wires and assemblies thereof
USRE32724E (en) * 1979-06-21 1988-08-02 American Hospital Supply Corporation Reusable medical electrode having disposable electrolyte carrier
US4832036A (en) * 1985-05-13 1989-05-23 Baxter International Inc. Medical electrode
US4838273A (en) * 1979-04-30 1989-06-13 Baxter International Inc. Medical electrode
US4852585A (en) * 1980-08-08 1989-08-01 Darox Corporation Tin-stannous chloride electrode element
US5305746A (en) * 1992-09-29 1994-04-26 Aspect Medical Systems, Inc. Disposable, pre-gelled, self-prepping electrode
US5326272A (en) * 1990-01-30 1994-07-05 Medtronic, Inc. Low profile electrode connector
US5431166A (en) * 1993-01-22 1995-07-11 Ludlow Corporation Low profile medical electrode
WO1996011631A1 (en) * 1994-10-17 1996-04-25 Biofield Corp. Dc biopotential sensing electrode and electroconductive medium for use therein
US5660177A (en) * 1991-11-04 1997-08-26 Biofield Corp. D.C. biopotential sensing electrode assemblies for apparatus for disease, injury and bodily condition screening or sensing
US5823957A (en) * 1994-10-17 1998-10-20 Biofield Corp D.C. biopotential sensing electrode and electroconductive medium for use therein
US6254614B1 (en) * 1999-10-18 2001-07-03 Jerry M. Jesseph Device and method for improved diagnosis and treatment of cancer
US20020107549A1 (en) * 2000-09-18 2002-08-08 Cameron Health, Inc. Subcutaneous electrode with improved contact shape for transthorasic conduction
US6711427B1 (en) 2002-02-13 2004-03-23 Milwaukee Electronics Corporation Skin abrading medical electrode mounting and packaging system
US20070167089A1 (en) * 2006-01-17 2007-07-19 Stephane Gobron Multi-lead keyhole connector
US20070260133A1 (en) * 2006-05-08 2007-11-08 Tycohealthcare Group Lp Radial electrode array
US20080081954A1 (en) * 2006-09-28 2008-04-03 Meyer Peter F Cable monitoring apparatus
US20080177168A1 (en) * 2006-12-05 2008-07-24 Mark Callahan Ecg lead wire organizer and dispenser
US20090088652A1 (en) * 2007-09-28 2009-04-02 Kathleen Tremblay Physiological sensor placement and signal transmission device
US20090227856A1 (en) * 2007-12-21 2009-09-10 Brian Keith Russell Electrocardiogram sensor
US7658196B2 (en) 2005-02-24 2010-02-09 Ethicon Endo-Surgery, Inc. System and method for determining implanted device orientation
US20100140500A1 (en) * 2007-06-19 2010-06-10 Therapy Positioning Technologies, Llc Apparatus and method for the treatment of breast cancer with particle beams
US7775966B2 (en) 2005-02-24 2010-08-17 Ethicon Endo-Surgery, Inc. Non-invasive pressure measurement in a fluid adjustable restrictive device
US7775215B2 (en) 2005-02-24 2010-08-17 Ethicon Endo-Surgery, Inc. System and method for determining implanted device positioning and obtaining pressure data
US20100292605A1 (en) * 2009-05-14 2010-11-18 Dragerwerk AG & Co. KGaA Double temperature sensor
US7844342B2 (en) 2008-02-07 2010-11-30 Ethicon Endo-Surgery, Inc. Powering implantable restriction systems using light
US7927270B2 (en) 2005-02-24 2011-04-19 Ethicon Endo-Surgery, Inc. External mechanical pressure sensor for gastric band pressure measurements
US7978064B2 (en) 2005-04-28 2011-07-12 Proteus Biomedical, Inc. Communication system with partial power source
US8016744B2 (en) 2005-02-24 2011-09-13 Ethicon Endo-Surgery, Inc. External pressure-based gastric band adjustment system and method
US8016745B2 (en) 2005-02-24 2011-09-13 Ethicon Endo-Surgery, Inc. Monitoring of a food intake restriction device
US8036748B2 (en) 2008-11-13 2011-10-11 Proteus Biomedical, Inc. Ingestible therapy activator system and method
US8034065B2 (en) 2008-02-26 2011-10-11 Ethicon Endo-Surgery, Inc. Controlling pressure in adjustable restriction devices
US8055334B2 (en) 2008-12-11 2011-11-08 Proteus Biomedical, Inc. Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same
US8054140B2 (en) 2006-10-17 2011-11-08 Proteus Biomedical, Inc. Low voltage oscillator for medical devices
US8057492B2 (en) 2008-02-12 2011-11-15 Ethicon Endo-Surgery, Inc. Automatically adjusting band system with MEMS pump
US8066629B2 (en) 2005-02-24 2011-11-29 Ethicon Endo-Surgery, Inc. Apparatus for adjustment and sensing of gastric band pressure
US8100870B2 (en) 2007-12-14 2012-01-24 Ethicon Endo-Surgery, Inc. Adjustable height gastric restriction devices and methods
US8114345B2 (en) 2008-02-08 2012-02-14 Ethicon Endo-Surgery, Inc. System and method of sterilizing an implantable medical device
US8115618B2 (en) 2007-05-24 2012-02-14 Proteus Biomedical, Inc. RFID antenna for in-body device
US8114021B2 (en) 2008-12-15 2012-02-14 Proteus Biomedical, Inc. Body-associated receiver and method
US8142452B2 (en) 2007-12-27 2012-03-27 Ethicon Endo-Surgery, Inc. Controlling pressure in adjustable restriction devices
US8152710B2 (en) 2006-04-06 2012-04-10 Ethicon Endo-Surgery, Inc. Physiological parameter analysis for an implantable restriction device and a data logger
US8187163B2 (en) 2007-12-10 2012-05-29 Ethicon Endo-Surgery, Inc. Methods for implanting a gastric restriction device
US8187162B2 (en) 2008-03-06 2012-05-29 Ethicon Endo-Surgery, Inc. Reorientation port
US8192350B2 (en) 2008-01-28 2012-06-05 Ethicon Endo-Surgery, Inc. Methods and devices for measuring impedance in a gastric restriction system
US8221439B2 (en) 2008-02-07 2012-07-17 Ethicon Endo-Surgery, Inc. Powering implantable restriction systems using kinetic motion
US8233995B2 (en) 2008-03-06 2012-07-31 Ethicon Endo-Surgery, Inc. System and method of aligning an implantable antenna
US8238996B2 (en) 2006-12-05 2012-08-07 Tyco Healthcare Group Lp Electrode array
US8258962B2 (en) 2008-03-05 2012-09-04 Proteus Biomedical, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US8337389B2 (en) 2008-01-28 2012-12-25 Ethicon Endo-Surgery, Inc. Methods and devices for diagnosing performance of a gastric restriction system
US8377079B2 (en) 2007-12-27 2013-02-19 Ethicon Endo-Surgery, Inc. Constant force mechanisms for regulating restriction devices
US8540664B2 (en) 2009-03-25 2013-09-24 Proteus Digital Health, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
US8540633B2 (en) 2008-08-13 2013-09-24 Proteus Digital Health, Inc. Identifier circuits for generating unique identifiable indicators and techniques for producing same
US8547248B2 (en) 2005-09-01 2013-10-01 Proteus Digital Health, Inc. Implantable zero-wire communications system
US8545402B2 (en) 2009-04-28 2013-10-01 Proteus Digital Health, Inc. Highly reliable ingestible event markers and methods for using the same
US8558563B2 (en) 2009-08-21 2013-10-15 Proteus Digital Health, Inc. Apparatus and method for measuring biochemical parameters
US8568160B2 (en) 2010-07-29 2013-10-29 Covidien Lp ECG adapter system and method
US8591395B2 (en) 2008-01-28 2013-11-26 Ethicon Endo-Surgery, Inc. Gastric restriction device data handling devices and methods
US8591532B2 (en) 2008-02-12 2013-11-26 Ethicon Endo-Sugery, Inc. Automatically adjusting band system
US8597186B2 (en) 2009-01-06 2013-12-03 Proteus Digital Health, Inc. Pharmaceutical dosages delivery system
US8668651B2 (en) 2006-12-05 2014-03-11 Covidien Lp ECG lead set and ECG adapter system
US8694080B2 (en) 2009-10-21 2014-04-08 Covidien Lp ECG lead system
US8690611B2 (en) 2007-12-11 2014-04-08 Covidien Lp ECG electrode connector
US8706217B2 (en) 2000-09-18 2014-04-22 Cameron Health Cardioverter-defibrillator having a focused shocking area and orientation thereof
US8718193B2 (en) 2006-11-20 2014-05-06 Proteus Digital Health, Inc. Active signal processing personal health signal receivers
US8730031B2 (en) 2005-04-28 2014-05-20 Proteus Digital Health, Inc. Communication system using an implantable device
US20140187063A1 (en) * 2012-12-31 2014-07-03 Suunto Oy Male end of a telemetric transceiver
US8784308B2 (en) 2009-12-02 2014-07-22 Proteus Digital Health, Inc. Integrated ingestible event marker system with pharmaceutical product
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US8831720B2 (en) 2000-09-18 2014-09-09 Cameron Health, Inc. Method of implanting and using a subcutaneous defibrillator
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US8858432B2 (en) 2007-02-01 2014-10-14 Proteus Digital Health, Inc. Ingestible event marker systems
US8868453B2 (en) 2009-11-04 2014-10-21 Proteus Digital Health, Inc. System for supply chain management
US8870742B2 (en) 2006-04-06 2014-10-28 Ethicon Endo-Surgery, Inc. GUI for an implantable restriction device and a data logger
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
US8932221B2 (en) 2007-03-09 2015-01-13 Proteus Digital Health, Inc. In-body device having a multi-directional transmitter
US8945005B2 (en) 2006-10-25 2015-02-03 Proteus Digital Health, Inc. Controlled activation ingestible identifier
US8956287B2 (en) 2006-05-02 2015-02-17 Proteus Digital Health, Inc. Patient customized therapeutic regimens
US8956288B2 (en) 2007-02-14 2015-02-17 Proteus Digital Health, Inc. In-body power source having high surface area electrode
US8961412B2 (en) 2007-09-25 2015-02-24 Proteus Digital Health, Inc. In-body device with virtual dipole signal amplification
US9014779B2 (en) 2010-02-01 2015-04-21 Proteus Digital Health, Inc. Data gathering system
US9107806B2 (en) 2010-11-22 2015-08-18 Proteus Digital Health, Inc. Ingestible device with pharmaceutical product
USD737979S1 (en) 2008-12-09 2015-09-01 Covidien Lp ECG electrode connector
US9138589B2 (en) 2001-11-21 2015-09-22 Cameron Health, Inc. Apparatus and method for identifying atrial arrhythmia by far-field sensing
US9144683B2 (en) 2000-09-18 2015-09-29 Cameron Health, Inc. Post-shock treatment in a subcutaneous device
US9149423B2 (en) 2009-05-12 2015-10-06 Proteus Digital Health, Inc. Ingestible event markers comprising an ingestible component
US9198608B2 (en) 2005-04-28 2015-12-01 Proteus Digital Health, Inc. Communication system incorporated in a container
US9235683B2 (en) 2011-11-09 2016-01-12 Proteus Digital Health, Inc. Apparatus, system, and method for managing adherence to a regimen
US9270503B2 (en) 2013-09-20 2016-02-23 Proteus Digital Health, Inc. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US9268909B2 (en) 2012-10-18 2016-02-23 Proteus Digital Health, Inc. Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device
US9270025B2 (en) 2007-03-09 2016-02-23 Proteus Digital Health, Inc. In-body device having deployable antenna
US9271897B2 (en) 2012-07-23 2016-03-01 Proteus Digital Health, Inc. Techniques for manufacturing ingestible event markers comprising an ingestible component
US9408547B2 (en) 2011-07-22 2016-08-09 Covidien Lp ECG electrode connector
US9408546B2 (en) 2013-03-15 2016-08-09 Covidien Lp Radiolucent ECG electrode system
US9439566B2 (en) 2008-12-15 2016-09-13 Proteus Digital Health, Inc. Re-wearable wireless device
US9439599B2 (en) 2011-03-11 2016-09-13 Proteus Digital Health, Inc. Wearable personal body associated device with various physical configurations
USD771818S1 (en) 2013-03-15 2016-11-15 Covidien Lp ECG electrode connector
US9577864B2 (en) 2013-09-24 2017-02-21 Proteus Digital Health, Inc. Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance
US9597487B2 (en) 2010-04-07 2017-03-21 Proteus Digital Health, Inc. Miniature ingestible device
US9603550B2 (en) 2008-07-08 2017-03-28 Proteus Digital Health, Inc. State characterization based on multi-variate data fusion techniques
US9659423B2 (en) 2008-12-15 2017-05-23 Proteus Digital Health, Inc. Personal authentication apparatus system and method
US9693701B2 (en) 2013-03-15 2017-07-04 Covidien Lp Electrode connector design to aid in correct placement
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US9883819B2 (en) 2009-01-06 2018-02-06 Proteus Digital Health, Inc. Ingestion-related biofeedback and personalized medical therapy method and system
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US10175376B2 (en) 2013-03-15 2019-01-08 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
US10187121B2 (en) 2016-07-22 2019-01-22 Proteus Digital Health, Inc. Electromagnetic sensing and detection of ingestible event markers
US10223905B2 (en) 2011-07-21 2019-03-05 Proteus Digital Health, Inc. Mobile device and system for detection and communication of information received from an ingestible device
US10398161B2 (en) 2014-01-21 2019-09-03 Proteus Digital Heal Th, Inc. Masticable ingestible product and communication system therefor
US20190380602A1 (en) * 2018-06-15 2019-12-19 Johnson Electric S.A. Medical sensor
US10529044B2 (en) 2010-05-19 2020-01-07 Proteus Digital Health, Inc. Tracking and delivery confirmation of pharmaceutical products
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
US11149123B2 (en) 2013-01-29 2021-10-19 Otsuka Pharmaceutical Co., Ltd. Highly-swellable polymeric films and compositions comprising the same
US11158149B2 (en) 2013-03-15 2021-10-26 Otsuka Pharmaceutical Co., Ltd. Personal authentication apparatus system and method
US11529071B2 (en) 2016-10-26 2022-12-20 Otsuka Pharmaceutical Co., Ltd. Methods for manufacturing capsules with ingestible event markers
US11744481B2 (en) 2013-03-15 2023-09-05 Otsuka Pharmaceutical Co., Ltd. System, apparatus and methods for data collection and assessing outcomes

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2055540A (en) * 1933-12-18 1936-09-29 Gen Therapeutics Corp Process and apparatus for treating pathological conditions
US3340868A (en) * 1965-03-05 1967-09-12 Gen Electric Body signal pickup electrode
US3534727A (en) * 1967-03-24 1970-10-20 Nasa Biomedical electrode arrangement
US3545432A (en) * 1967-07-24 1970-12-08 Gulton Ind Inc Body electrode assembly
US3581736A (en) * 1968-12-20 1971-06-01 Ilias Zenkich Electrocardiograph electrode
US3587565A (en) * 1969-08-25 1971-06-28 Cardiac Electronics Inc Disposable electrode
US3696807A (en) * 1970-02-13 1972-10-10 Mdm Corp Medical electrode with relatively rigid electrolyte cup
US3701346A (en) * 1971-01-04 1972-10-31 Bionetics Inc Medical electrode

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2055540A (en) * 1933-12-18 1936-09-29 Gen Therapeutics Corp Process and apparatus for treating pathological conditions
US3340868A (en) * 1965-03-05 1967-09-12 Gen Electric Body signal pickup electrode
US3534727A (en) * 1967-03-24 1970-10-20 Nasa Biomedical electrode arrangement
US3545432A (en) * 1967-07-24 1970-12-08 Gulton Ind Inc Body electrode assembly
US3581736A (en) * 1968-12-20 1971-06-01 Ilias Zenkich Electrocardiograph electrode
US3587565A (en) * 1969-08-25 1971-06-28 Cardiac Electronics Inc Disposable electrode
US3696807A (en) * 1970-02-13 1972-10-10 Mdm Corp Medical electrode with relatively rigid electrolyte cup
US3701346A (en) * 1971-01-04 1972-10-31 Bionetics Inc Medical electrode

Cited By (236)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923042A (en) * 1973-10-15 1975-12-02 Medicor Muevek Electrical detector/transducer/applicable on the skin surface for biometrical observations
US3976055A (en) * 1973-12-17 1976-08-24 Ndm Corporation Electrode and conductor therefor
US4067322A (en) * 1974-07-19 1978-01-10 Johnson Joseph H Disposable, pre-gel body electrodes
US4040412A (en) * 1974-08-09 1977-08-09 Sato Takuya R Bioelectrodes
US4077397A (en) * 1974-10-07 1978-03-07 Baxter Travenol Laboratories, Inc. Diagnostic electrode assembly
US4077398A (en) * 1974-10-07 1978-03-07 Baxter Travenol Laboratories, Inc. Diagnostic electrode assembly
US4092985A (en) * 1974-11-25 1978-06-06 John George Kaufman Body electrode for electro-medical use
US3972329A (en) * 1974-11-25 1976-08-03 Kaufman John George Body electrode for electro-medical use
US3993049A (en) * 1974-12-26 1976-11-23 Kater John A R Electrodes and materials therefor
US3961623A (en) * 1975-01-17 1976-06-08 Medical Research Laboratories, Inc. Method of using a disposable electrode pad
US3977392A (en) * 1975-04-21 1976-08-31 Eastprint, Inc. Medical electrode
US3973557A (en) * 1975-04-21 1976-08-10 Allison Kenneth C Electrode
US3964469A (en) * 1975-04-21 1976-06-22 Eastprint, Inc. Disposable electrode
US3989035A (en) * 1975-08-04 1976-11-02 Stemmen Laboratory, Inc. Disposable medical electrode
US4029086A (en) * 1975-08-11 1977-06-14 Consolidated Medical Equipment, Inc. Electrode arrangement
US4050453A (en) * 1976-02-03 1977-09-27 Concept, Inc. Radiotransparent electrode
US4034854A (en) * 1976-07-16 1977-07-12 M I Systems, Inc. Electrode package
US4063352A (en) * 1976-07-16 1977-12-20 M I Systems, Inc. Method of making electrode package
US4166456A (en) * 1977-01-17 1979-09-04 Vaughn Corporation Carrier release sheet
WO1979000042A1 (en) * 1977-07-13 1979-02-08 A Mercuri Biomedical electrode assembly
US4161174A (en) * 1977-07-13 1979-07-17 Mercuri Albert R Biomedical electrode assembly
EP0000759A1 (en) * 1977-08-03 1979-02-21 Siemens Aktiengesellschaft Electrode
DE2735050A1 (en) * 1977-08-03 1979-02-08 Siemens Ag Electrode accepting and sending physiological signals - contains polyether foam inserts having closed pore surface on application side
FR2416001A1 (en) * 1978-02-01 1979-08-31 Bard Inc C R BIPOLAR TRANSCUTANEOUS ELECTRODE
US4177817A (en) * 1978-02-01 1979-12-11 C. R. Bard, Inc. Dual terminal transcutaneous electrode
US4196737A (en) * 1978-04-21 1980-04-08 C. R. Bard, Inc. Transcutaneous electrode construction
US4584962A (en) * 1979-04-30 1986-04-29 Ndm Corporation Medical electrodes and dispensing conditioner therefor
US4838273A (en) * 1979-04-30 1989-06-13 Baxter International Inc. Medical electrode
US4674511A (en) * 1979-04-30 1987-06-23 American Hospital Supply Corporation Medical electrode
US4590089A (en) * 1979-04-30 1986-05-20 Ndm Corporation Medical electrodes and dispensing conditioner therefor
US4543958A (en) * 1979-04-30 1985-10-01 Ndm Corporation Medical electrode assembly
US4319579A (en) * 1979-06-21 1982-03-16 Ndm Corporation Reusable medical electrode having disposable electrolyte carrier
USRE32724E (en) * 1979-06-21 1988-08-02 American Hospital Supply Corporation Reusable medical electrode having disposable electrolyte carrier
US4522211A (en) * 1979-12-06 1985-06-11 C. R. Bard, Inc. Medical electrode construction
US4393584A (en) * 1979-12-06 1983-07-19 C. R. Bard, Inc. Method of manufacture of electrode construction
US4353373A (en) * 1980-04-17 1982-10-12 Ferris Manufacturing Corp. EKG Electrode and package
US4441500A (en) * 1980-04-17 1984-04-10 Ferris Manufacturing Corp. EKG Electrode
US4327737A (en) * 1980-05-15 1982-05-04 Roman Szpur Medical electrode assembly
US4852585A (en) * 1980-08-08 1989-08-01 Darox Corporation Tin-stannous chloride electrode element
US4524775A (en) * 1982-02-15 1985-06-25 Jan Rasmussen Medical electrode and a method of manufacturing same
US4832036A (en) * 1985-05-13 1989-05-23 Baxter International Inc. Medical electrode
US4685467A (en) * 1985-07-10 1987-08-11 American Hospital Supply Corporation X-ray transparent medical electrodes and lead wires and assemblies thereof
US4669479A (en) * 1985-08-21 1987-06-02 Spring Creek Institute, Inc. Dry electrode system for detection of biopotentials
US5326272A (en) * 1990-01-30 1994-07-05 Medtronic, Inc. Low profile electrode connector
US5660177A (en) * 1991-11-04 1997-08-26 Biofield Corp. D.C. biopotential sensing electrode assemblies for apparatus for disease, injury and bodily condition screening or sensing
US5305746A (en) * 1992-09-29 1994-04-26 Aspect Medical Systems, Inc. Disposable, pre-gelled, self-prepping electrode
US5431166A (en) * 1993-01-22 1995-07-11 Ludlow Corporation Low profile medical electrode
US5823957A (en) * 1994-10-17 1998-10-20 Biofield Corp D.C. biopotential sensing electrode and electroconductive medium for use therein
WO1996011631A1 (en) * 1994-10-17 1996-04-25 Biofield Corp. Dc biopotential sensing electrode and electroconductive medium for use therein
US20030233110A1 (en) * 1999-10-18 2003-12-18 Jesseph Jerry M. Device and method for improved diagnosis and treatment of cancer
US6254614B1 (en) * 1999-10-18 2001-07-03 Jerry M. Jesseph Device and method for improved diagnosis and treatment of cancer
US6569176B2 (en) 1999-10-18 2003-05-27 Jerry M. Jesseph Device and method for improved diagnosis and treatment of cancer
US20050240232A9 (en) * 2000-09-18 2005-10-27 Cameron Health, Inc. Subcutaneous electrode with improved contact shape for transthorasic conduction
US20020107549A1 (en) * 2000-09-18 2002-08-08 Cameron Health, Inc. Subcutaneous electrode with improved contact shape for transthorasic conduction
US7065410B2 (en) * 2000-09-18 2006-06-20 Cameron Health, Inc. Subcutaneous electrode with improved contact shape for transthorasic conduction
US8831720B2 (en) 2000-09-18 2014-09-09 Cameron Health, Inc. Method of implanting and using a subcutaneous defibrillator
US8706217B2 (en) 2000-09-18 2014-04-22 Cameron Health Cardioverter-defibrillator having a focused shocking area and orientation thereof
US7657322B2 (en) 2000-09-18 2010-02-02 Cameron Health, Inc. Subcutaneous electrode with improved contact shape for transthoracic conduction
US9144683B2 (en) 2000-09-18 2015-09-29 Cameron Health, Inc. Post-shock treatment in a subcutaneous device
US9138589B2 (en) 2001-11-21 2015-09-22 Cameron Health, Inc. Apparatus and method for identifying atrial arrhythmia by far-field sensing
US9522283B2 (en) 2001-11-21 2016-12-20 Cameron Health Inc. Apparatus and method for identifying atrial arrhythmia by far-field sensing
US9993653B2 (en) 2001-11-21 2018-06-12 Cameron Health, Inc. Apparatus and method for identifying atrial arrhythmia by far-field sensing
US6711427B1 (en) 2002-02-13 2004-03-23 Milwaukee Electronics Corporation Skin abrading medical electrode mounting and packaging system
US7658196B2 (en) 2005-02-24 2010-02-09 Ethicon Endo-Surgery, Inc. System and method for determining implanted device orientation
US7927270B2 (en) 2005-02-24 2011-04-19 Ethicon Endo-Surgery, Inc. External mechanical pressure sensor for gastric band pressure measurements
US8066629B2 (en) 2005-02-24 2011-11-29 Ethicon Endo-Surgery, Inc. Apparatus for adjustment and sensing of gastric band pressure
US8016745B2 (en) 2005-02-24 2011-09-13 Ethicon Endo-Surgery, Inc. Monitoring of a food intake restriction device
US8016744B2 (en) 2005-02-24 2011-09-13 Ethicon Endo-Surgery, Inc. External pressure-based gastric band adjustment system and method
US7775966B2 (en) 2005-02-24 2010-08-17 Ethicon Endo-Surgery, Inc. Non-invasive pressure measurement in a fluid adjustable restrictive device
US7775215B2 (en) 2005-02-24 2010-08-17 Ethicon Endo-Surgery, Inc. System and method for determining implanted device positioning and obtaining pressure data
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US10517507B2 (en) 2005-04-28 2019-12-31 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US9119554B2 (en) 2005-04-28 2015-09-01 Proteus Digital Health, Inc. Pharma-informatics system
US11476952B2 (en) 2005-04-28 2022-10-18 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
US7978064B2 (en) 2005-04-28 2011-07-12 Proteus Biomedical, Inc. Communication system with partial power source
US8730031B2 (en) 2005-04-28 2014-05-20 Proteus Digital Health, Inc. Communication system using an implantable device
US9597010B2 (en) 2005-04-28 2017-03-21 Proteus Digital Health, Inc. Communication system using an implantable device
US8674825B2 (en) 2005-04-28 2014-03-18 Proteus Digital Health, Inc. Pharma-informatics system
US10610128B2 (en) 2005-04-28 2020-04-07 Proteus Digital Health, Inc. Pharma-informatics system
US10542909B2 (en) 2005-04-28 2020-01-28 Proteus Digital Health, Inc. Communication system with partial power source
US9649066B2 (en) 2005-04-28 2017-05-16 Proteus Digital Health, Inc. Communication system with partial power source
US8847766B2 (en) 2005-04-28 2014-09-30 Proteus Digital Health, Inc. Pharma-informatics system
US9161707B2 (en) 2005-04-28 2015-10-20 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US9439582B2 (en) 2005-04-28 2016-09-13 Proteus Digital Health, Inc. Communication system with remote activation
US9198608B2 (en) 2005-04-28 2015-12-01 Proteus Digital Health, Inc. Communication system incorporated in a container
US8816847B2 (en) 2005-04-28 2014-08-26 Proteus Digital Health, Inc. Communication system with partial power source
US9681842B2 (en) 2005-04-28 2017-06-20 Proteus Digital Health, Inc. Pharma-informatics system
US9962107B2 (en) 2005-04-28 2018-05-08 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
US8547248B2 (en) 2005-09-01 2013-10-01 Proteus Digital Health, Inc. Implantable zero-wire communications system
US7364440B2 (en) 2006-01-17 2008-04-29 Lifesync Corporation Multi-lead keyhole connector
US20070167089A1 (en) * 2006-01-17 2007-07-19 Stephane Gobron Multi-lead keyhole connector
US8152710B2 (en) 2006-04-06 2012-04-10 Ethicon Endo-Surgery, Inc. Physiological parameter analysis for an implantable restriction device and a data logger
US8870742B2 (en) 2006-04-06 2014-10-28 Ethicon Endo-Surgery, Inc. GUI for an implantable restriction device and a data logger
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US11928614B2 (en) 2006-05-02 2024-03-12 Otsuka Pharmaceutical Co., Ltd. Patient customized therapeutic regimens
US8956287B2 (en) 2006-05-02 2015-02-17 Proteus Digital Health, Inc. Patient customized therapeutic regimens
US20100022865A1 (en) * 2006-05-08 2010-01-28 Tyco Healthcare Group Lp Radial Electrode Array
US20070260133A1 (en) * 2006-05-08 2007-11-08 Tycohealthcare Group Lp Radial electrode array
US7616980B2 (en) 2006-05-08 2009-11-10 Tyco Healthcare Group Lp Radial electrode array
US7925323B2 (en) 2006-05-08 2011-04-12 Tyco Healthcare Group Lp Radial electrode array
US8821405B2 (en) 2006-09-28 2014-09-02 Covidien Lp Cable monitoring apparatus
US20080081954A1 (en) * 2006-09-28 2008-04-03 Meyer Peter F Cable monitoring apparatus
US8109883B2 (en) 2006-09-28 2012-02-07 Tyco Healthcare Group Lp Cable monitoring apparatus
US8054140B2 (en) 2006-10-17 2011-11-08 Proteus Biomedical, Inc. Low voltage oscillator for medical devices
US8945005B2 (en) 2006-10-25 2015-02-03 Proteus Digital Health, Inc. Controlled activation ingestible identifier
US10238604B2 (en) 2006-10-25 2019-03-26 Proteus Digital Health, Inc. Controlled activation ingestible identifier
US11357730B2 (en) 2006-10-25 2022-06-14 Otsuka Pharmaceutical Co., Ltd. Controlled activation ingestible identifier
US9444503B2 (en) 2006-11-20 2016-09-13 Proteus Digital Health, Inc. Active signal processing personal health signal receivers
US9083589B2 (en) 2006-11-20 2015-07-14 Proteus Digital Health, Inc. Active signal processing personal health signal receivers
US8718193B2 (en) 2006-11-20 2014-05-06 Proteus Digital Health, Inc. Active signal processing personal health signal receivers
US8668651B2 (en) 2006-12-05 2014-03-11 Covidien Lp ECG lead set and ECG adapter system
US8180425B2 (en) 2006-12-05 2012-05-15 Tyco Healthcare Group Lp ECG lead wire organizer and dispenser
US8560043B2 (en) 2006-12-05 2013-10-15 Covidien Lp ECG lead wire organizer and dispenser
US8571627B2 (en) 2006-12-05 2013-10-29 Covidien Lp ECG lead wire organizer and dispenser
US20080177168A1 (en) * 2006-12-05 2008-07-24 Mark Callahan Ecg lead wire organizer and dispenser
US9072444B2 (en) 2006-12-05 2015-07-07 Covidien Lp ECG lead set and ECG adapter system
US8238996B2 (en) 2006-12-05 2012-08-07 Tyco Healthcare Group Lp Electrode array
US8868152B2 (en) 2006-12-05 2014-10-21 Covidien Lp Electrode array
US10441194B2 (en) 2007-02-01 2019-10-15 Proteus Digital Heal Th, Inc. Ingestible event marker systems
US8858432B2 (en) 2007-02-01 2014-10-14 Proteus Digital Health, Inc. Ingestible event marker systems
US8956288B2 (en) 2007-02-14 2015-02-17 Proteus Digital Health, Inc. In-body power source having high surface area electrode
US11464423B2 (en) 2007-02-14 2022-10-11 Otsuka Pharmaceutical Co., Ltd. In-body power source having high surface area electrode
US9270025B2 (en) 2007-03-09 2016-02-23 Proteus Digital Health, Inc. In-body device having deployable antenna
US8932221B2 (en) 2007-03-09 2015-01-13 Proteus Digital Health, Inc. In-body device having a multi-directional transmitter
US8115618B2 (en) 2007-05-24 2012-02-14 Proteus Biomedical, Inc. RFID antenna for in-body device
US8540632B2 (en) 2007-05-24 2013-09-24 Proteus Digital Health, Inc. Low profile antenna for in body device
US10517506B2 (en) 2007-05-24 2019-12-31 Proteus Digital Health, Inc. Low profile antenna for in body device
US20100140500A1 (en) * 2007-06-19 2010-06-10 Therapy Positioning Technologies, Llc Apparatus and method for the treatment of breast cancer with particle beams
US8961412B2 (en) 2007-09-25 2015-02-24 Proteus Digital Health, Inc. In-body device with virtual dipole signal amplification
US9433371B2 (en) 2007-09-25 2016-09-06 Proteus Digital Health, Inc. In-body device with virtual dipole signal amplification
US20090088652A1 (en) * 2007-09-28 2009-04-02 Kathleen Tremblay Physiological sensor placement and signal transmission device
US8798708B2 (en) 2007-09-28 2014-08-05 Covidien Lp Physiological sensor placement and signal transmission device
US8187163B2 (en) 2007-12-10 2012-05-29 Ethicon Endo-Surgery, Inc. Methods for implanting a gastric restriction device
US8690611B2 (en) 2007-12-11 2014-04-08 Covidien Lp ECG electrode connector
US9107594B2 (en) 2007-12-11 2015-08-18 Covidien Lp ECG electrode connector
US8795004B2 (en) 2007-12-11 2014-08-05 Covidien, LP ECG electrode connector
US8100870B2 (en) 2007-12-14 2012-01-24 Ethicon Endo-Surgery, Inc. Adjustable height gastric restriction devices and methods
US20090227856A1 (en) * 2007-12-21 2009-09-10 Brian Keith Russell Electrocardiogram sensor
US8377079B2 (en) 2007-12-27 2013-02-19 Ethicon Endo-Surgery, Inc. Constant force mechanisms for regulating restriction devices
US8142452B2 (en) 2007-12-27 2012-03-27 Ethicon Endo-Surgery, Inc. Controlling pressure in adjustable restriction devices
US8337389B2 (en) 2008-01-28 2012-12-25 Ethicon Endo-Surgery, Inc. Methods and devices for diagnosing performance of a gastric restriction system
US8192350B2 (en) 2008-01-28 2012-06-05 Ethicon Endo-Surgery, Inc. Methods and devices for measuring impedance in a gastric restriction system
US8591395B2 (en) 2008-01-28 2013-11-26 Ethicon Endo-Surgery, Inc. Gastric restriction device data handling devices and methods
US7844342B2 (en) 2008-02-07 2010-11-30 Ethicon Endo-Surgery, Inc. Powering implantable restriction systems using light
US8221439B2 (en) 2008-02-07 2012-07-17 Ethicon Endo-Surgery, Inc. Powering implantable restriction systems using kinetic motion
US8114345B2 (en) 2008-02-08 2012-02-14 Ethicon Endo-Surgery, Inc. System and method of sterilizing an implantable medical device
US8591532B2 (en) 2008-02-12 2013-11-26 Ethicon Endo-Sugery, Inc. Automatically adjusting band system
US8057492B2 (en) 2008-02-12 2011-11-15 Ethicon Endo-Surgery, Inc. Automatically adjusting band system with MEMS pump
US8034065B2 (en) 2008-02-26 2011-10-11 Ethicon Endo-Surgery, Inc. Controlling pressure in adjustable restriction devices
US8258962B2 (en) 2008-03-05 2012-09-04 Proteus Biomedical, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US9060708B2 (en) 2008-03-05 2015-06-23 Proteus Digital Health, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US9258035B2 (en) 2008-03-05 2016-02-09 Proteus Digital Health, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US8542123B2 (en) 2008-03-05 2013-09-24 Proteus Digital Health, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US8810409B2 (en) 2008-03-05 2014-08-19 Proteus Digital Health, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US8233995B2 (en) 2008-03-06 2012-07-31 Ethicon Endo-Surgery, Inc. System and method of aligning an implantable antenna
US8187162B2 (en) 2008-03-06 2012-05-29 Ethicon Endo-Surgery, Inc. Reorientation port
US10682071B2 (en) 2008-07-08 2020-06-16 Proteus Digital Health, Inc. State characterization based on multi-variate data fusion techniques
US9603550B2 (en) 2008-07-08 2017-03-28 Proteus Digital Health, Inc. State characterization based on multi-variate data fusion techniques
US11217342B2 (en) 2008-07-08 2022-01-04 Otsuka Pharmaceutical Co., Ltd. Ingestible event marker data framework
US8540633B2 (en) 2008-08-13 2013-09-24 Proteus Digital Health, Inc. Identifier circuits for generating unique identifiable indicators and techniques for producing same
US9415010B2 (en) 2008-08-13 2016-08-16 Proteus Digital Health, Inc. Ingestible circuitry
US8721540B2 (en) 2008-08-13 2014-05-13 Proteus Digital Health, Inc. Ingestible circuitry
US8036748B2 (en) 2008-11-13 2011-10-11 Proteus Biomedical, Inc. Ingestible therapy activator system and method
USD737979S1 (en) 2008-12-09 2015-09-01 Covidien Lp ECG electrode connector
US8583227B2 (en) 2008-12-11 2013-11-12 Proteus Digital Health, Inc. Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same
US8055334B2 (en) 2008-12-11 2011-11-08 Proteus Biomedical, Inc. Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same
US9149577B2 (en) 2008-12-15 2015-10-06 Proteus Digital Health, Inc. Body-associated receiver and method
US9659423B2 (en) 2008-12-15 2017-05-23 Proteus Digital Health, Inc. Personal authentication apparatus system and method
US8545436B2 (en) 2008-12-15 2013-10-01 Proteus Digital Health, Inc. Body-associated receiver and method
US8114021B2 (en) 2008-12-15 2012-02-14 Proteus Biomedical, Inc. Body-associated receiver and method
US9439566B2 (en) 2008-12-15 2016-09-13 Proteus Digital Health, Inc. Re-wearable wireless device
US8597186B2 (en) 2009-01-06 2013-12-03 Proteus Digital Health, Inc. Pharmaceutical dosages delivery system
US9883819B2 (en) 2009-01-06 2018-02-06 Proteus Digital Health, Inc. Ingestion-related biofeedback and personalized medical therapy method and system
US8540664B2 (en) 2009-03-25 2013-09-24 Proteus Digital Health, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
US9119918B2 (en) 2009-03-25 2015-09-01 Proteus Digital Health, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
US10588544B2 (en) 2009-04-28 2020-03-17 Proteus Digital Health, Inc. Highly reliable ingestible event markers and methods for using the same
US9320455B2 (en) 2009-04-28 2016-04-26 Proteus Digital Health, Inc. Highly reliable ingestible event markers and methods for using the same
US8545402B2 (en) 2009-04-28 2013-10-01 Proteus Digital Health, Inc. Highly reliable ingestible event markers and methods for using the same
US9149423B2 (en) 2009-05-12 2015-10-06 Proteus Digital Health, Inc. Ingestible event markers comprising an ingestible component
US8708926B2 (en) * 2009-05-14 2014-04-29 Drägerwerk AG & Co. KGaA Double temperature sensor
US20100292605A1 (en) * 2009-05-14 2010-11-18 Dragerwerk AG & Co. KGaA Double temperature sensor
US8558563B2 (en) 2009-08-21 2013-10-15 Proteus Digital Health, Inc. Apparatus and method for measuring biochemical parameters
US8694080B2 (en) 2009-10-21 2014-04-08 Covidien Lp ECG lead system
US8897865B2 (en) 2009-10-21 2014-11-25 Covidien Lp ECG lead system
US10305544B2 (en) 2009-11-04 2019-05-28 Proteus Digital Health, Inc. System for supply chain management
US8868453B2 (en) 2009-11-04 2014-10-21 Proteus Digital Health, Inc. System for supply chain management
US9941931B2 (en) 2009-11-04 2018-04-10 Proteus Digital Health, Inc. System for supply chain management
US8784308B2 (en) 2009-12-02 2014-07-22 Proteus Digital Health, Inc. Integrated ingestible event marker system with pharmaceutical product
US9014779B2 (en) 2010-02-01 2015-04-21 Proteus Digital Health, Inc. Data gathering system
US10376218B2 (en) 2010-02-01 2019-08-13 Proteus Digital Health, Inc. Data gathering system
US9597487B2 (en) 2010-04-07 2017-03-21 Proteus Digital Health, Inc. Miniature ingestible device
US11173290B2 (en) 2010-04-07 2021-11-16 Otsuka Pharmaceutical Co., Ltd. Miniature ingestible device
US10207093B2 (en) 2010-04-07 2019-02-19 Proteus Digital Health, Inc. Miniature ingestible device
US10529044B2 (en) 2010-05-19 2020-01-07 Proteus Digital Health, Inc. Tracking and delivery confirmation of pharmaceutical products
US8568160B2 (en) 2010-07-29 2013-10-29 Covidien Lp ECG adapter system and method
US11504511B2 (en) 2010-11-22 2022-11-22 Otsuka Pharmaceutical Co., Ltd. Ingestible device with pharmaceutical product
US9107806B2 (en) 2010-11-22 2015-08-18 Proteus Digital Health, Inc. Ingestible device with pharmaceutical product
US9439599B2 (en) 2011-03-11 2016-09-13 Proteus Digital Health, Inc. Wearable personal body associated device with various physical configurations
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US11229378B2 (en) 2011-07-11 2022-01-25 Otsuka Pharmaceutical Co., Ltd. Communication system with enhanced partial power source and method of manufacturing same
US10223905B2 (en) 2011-07-21 2019-03-05 Proteus Digital Health, Inc. Mobile device and system for detection and communication of information received from an ingestible device
US9408547B2 (en) 2011-07-22 2016-08-09 Covidien Lp ECG electrode connector
US9737226B2 (en) 2011-07-22 2017-08-22 Covidien Lp ECG electrode connector
US9235683B2 (en) 2011-11-09 2016-01-12 Proteus Digital Health, Inc. Apparatus, system, and method for managing adherence to a regimen
US9271897B2 (en) 2012-07-23 2016-03-01 Proteus Digital Health, Inc. Techniques for manufacturing ingestible event markers comprising an ingestible component
US9268909B2 (en) 2012-10-18 2016-02-23 Proteus Digital Health, Inc. Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device
US20140187063A1 (en) * 2012-12-31 2014-07-03 Suunto Oy Male end of a telemetric transceiver
US8814574B2 (en) * 2012-12-31 2014-08-26 Suunto Oy Male end of a telemetric transceiver
US11149123B2 (en) 2013-01-29 2021-10-19 Otsuka Pharmaceutical Co., Ltd. Highly-swellable polymeric films and compositions comprising the same
US9814404B2 (en) 2013-03-15 2017-11-14 Covidien Lp Radiolucent ECG electrode system
US9693701B2 (en) 2013-03-15 2017-07-04 Covidien Lp Electrode connector design to aid in correct placement
US10175376B2 (en) 2013-03-15 2019-01-08 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
US11158149B2 (en) 2013-03-15 2021-10-26 Otsuka Pharmaceutical Co., Ltd. Personal authentication apparatus system and method
US11744481B2 (en) 2013-03-15 2023-09-05 Otsuka Pharmaceutical Co., Ltd. System, apparatus and methods for data collection and assessing outcomes
USD771818S1 (en) 2013-03-15 2016-11-15 Covidien Lp ECG electrode connector
US11741771B2 (en) 2013-03-15 2023-08-29 Otsuka Pharmaceutical Co., Ltd. Personal authentication apparatus system and method
US9408546B2 (en) 2013-03-15 2016-08-09 Covidien Lp Radiolucent ECG electrode system
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US10421658B2 (en) 2013-08-30 2019-09-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US10498572B2 (en) 2013-09-20 2019-12-03 Proteus Digital Health, Inc. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US11102038B2 (en) 2013-09-20 2021-08-24 Otsuka Pharmaceutical Co., Ltd. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US10097388B2 (en) 2013-09-20 2018-10-09 Proteus Digital Health, Inc. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US9787511B2 (en) 2013-09-20 2017-10-10 Proteus Digital Health, Inc. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US9270503B2 (en) 2013-09-20 2016-02-23 Proteus Digital Health, Inc. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US9577864B2 (en) 2013-09-24 2017-02-21 Proteus Digital Health, Inc. Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US10398161B2 (en) 2014-01-21 2019-09-03 Proteus Digital Heal Th, Inc. Masticable ingestible product and communication system therefor
US11950615B2 (en) 2014-01-21 2024-04-09 Otsuka Pharmaceutical Co., Ltd. Masticable ingestible product and communication system therefor
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
US10797758B2 (en) 2016-07-22 2020-10-06 Proteus Digital Health, Inc. Electromagnetic sensing and detection of ingestible event markers
US10187121B2 (en) 2016-07-22 2019-01-22 Proteus Digital Health, Inc. Electromagnetic sensing and detection of ingestible event markers
US11529071B2 (en) 2016-10-26 2022-12-20 Otsuka Pharmaceutical Co., Ltd. Methods for manufacturing capsules with ingestible event markers
US11793419B2 (en) 2016-10-26 2023-10-24 Otsuka Pharmaceutical Co., Ltd. Methods for manufacturing capsules with ingestible event markers
US20190380602A1 (en) * 2018-06-15 2019-12-19 Johnson Electric S.A. Medical sensor
US11006882B2 (en) * 2018-06-15 2021-05-18 Johnson Electric International AG Medical sensor

Similar Documents

Publication Publication Date Title
US3828766A (en) Disposable medical electrode
US3701346A (en) Medical electrode
US3845757A (en) Biomedical monitoring electrode
US4088133A (en) Electrode for electrosurgical procedure
US3989035A (en) Disposable medical electrode
US4077397A (en) Diagnostic electrode assembly
US4077398A (en) Diagnostic electrode assembly
US4067322A (en) Disposable, pre-gel body electrodes
US3911906A (en) Dry applied and operably dry electrode device
US3830229A (en) Disposable body electrodes
US4051842A (en) Electrode and interfacing pad for electrical physiological systems
US3868946A (en) Medical electrode
US4444194A (en) Medical electrode assembly
US4441501A (en) Medical electrode
US4090752A (en) Diagnostic electrode assembly
US4196737A (en) Transcutaneous electrode construction
US4117841A (en) Medicated bandage pocket
US3085577A (en) Body electrode
US4727881A (en) Biomedical electrode
JPH06335459A (en) Biomedicine electrode
US4029086A (en) Electrode arrangement
US3518984A (en) Packaged diagnostic electrode device
JP2001506154A (en) Biomedical electrodes with disposable electrodes and reusable lead adapters that interface with standard lead connectors
US4391279A (en) Electrode belt
JPS6218151U (en)